April 9, 2024Neurology

Consistent Efficacy of Once-nightly Sodium Oxybate Regardless of Patient Demographic and Baseline Disease Characteristics (P10-9.008)

View Full Paper

Ask AI

Bookmark

Abstract

Once-nightly sodium oxybate (ON-SXB; FT218; LUMRYZ™) was investigated in patients with narcolepsy in the phase 3 REST-ON trial (NCT02720744). This post-hoc analysis assessed ON-SXB efficacy across participant subgroups.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thorpy et al. (2024) studied this question.

synapsesocial.com/papers/68e6feb4b6db643587678b54 https://doi.org/10.1212/wnl.0000000000204591

View Full Paper

Ask AI

Bookmark

Consistent Efficacy of Once-nightly Sodium Oxybate Regardless of Patient Demographic and Baseline Disease Characteristics (P10-9.008)

Abstract

Discussion

Cite This Study

Consistent Efficacy of Once-nightly Sodium Oxybate Regardless of Patient Demographic and Baseline Disease Characteristics (P10-9.008)

Abstract

Discussion

Cite This Study

Keep reading

Keep reading